Management — NMD Pharma
Management — NMD Pharma
Nmd Pharma A/S, Aarhus N | firma | krak.dk
NMD Pharma - Inkef capital
Tunge pengetanke klar til nye investeringer i biotekselskab fra Aarhus
Company Presentation
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma
Contact — NMD Pharma
NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
Company Presentation
NMD Pharma to advance neuromuscular disorder therapies with €38m Series A round
Big deal: NMD flexes series A muscles - Global University Venturing
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma - Capnova
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma
NMD Pharma
Company Presentation
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
Event: Aarhus - Brew Your Own: Meet the founders - Biopeople
